A 7-year-old girl was presented in the authors' department with decreased consciousness.
Introduction
Pilomyxoid astrocytoma (PMA) is a type of tumor resembling pilocytic astrocytoma (PA), yet differs in a clinical course and histopathological findings. As a new diagnosis, there were no treatment guidelines for PMA established. We reported a case of cystic PMA on suprasellar region in a 7-year-old girl at our institution.
Operative treatment
The authors performed an emergency ventriculo-peritoneal (VP)-shunt to reduce intracranial pressure (ICP) caused by hydrocephalus. Shortly after the procedure, patient's general condition improved. Craniotomy tumor removal was performed 2 weeks afterward using pterional transsylvian approach. The tumor was firm and reddish in color, it wrapped the internal carotid artery (ICA), the proximal part of middle cerebral artery, anterior cerebral artery, and its branches. Optic apparatus and pituitary stalk were also wrapped by the tumor [ Figure 2a ]. An intratumoral cyst was found containing a yellowish liquid. Tumor had extended into the third ventricle and attached in the wall of the third ventricle. The tumor was partially removed about 80%; parts that strongly attached to the ICA, pituitary stalk and hypothalamus were left behind [ Figure 2b ]. Postoperative CT showed reduction of the tumor mass with visible remnant especially at right parasellar area [ Figure 3a and b]. Radiotherapy was eventually proposed to control the residual tumor.
Adjuvant treatment
In the postoperative course, some neurological deficits included weakness on the extremities, headache, and visual problems were improved. Within 3 weeks after surgery, the patient was directly sent to the radiotherapy department to receive linear accelerator (LINAC) electra shot at 180 cGy for 20 times within 2 months. The mass measurement for radiation was constructed in three-dimensional and the area of radiation was extended to 2 mm of the tumor border. If the surrounding area is vital, we only radiate the tumor within the border. During radiation therapy, there was no major complaint, except minimal nausea. Concerning the child's growth, the patient was followed-up in the neurosurgery outpatient clinic, altogether with neuropediatrician, ophthalmologist and physiatrist. Further improvement on motor strength, visual acuity, and visual field were reported. Only slight astigmatism was found on both eyes. One-year postradiotherapy CT showed a significant reduction of the mass size [ Figure 3c and d].
Histopathological evaluation
The tumor cells are dominated markedly by mucoid matrix and composed of monomorphic bipolar cells with angiocentric cells arrangement [ Figure 4a -c]. This finding was consistent with the diagnosis of PMA. Cerebrospinal fluid (CSF) analysis did not reveal any malignant cells.
Discussion
Pilomyxoid astrocytoma was proposed in 1999 by Tihan et al. as a separate diagnosis from PA because of its histological configurations which determine patient's prognosis.
[1] As a recently described astrocytic neoplasm entity, this lesion has not been included in the current (2000) World Health Organization classification. [2] [3] [4] Characteristically, PMA is more aggressive with higher rate of local recurrence and leptomeningeal dissemination. [2] PMA usually found in infant and very young children (3 months to 2 years), with mean presentation about 10-18 months. [2, [4] [5] [6] [7] Some reports mentioned about PMA in older patients. [8, 9] The survival rates of PMA are worse than PA; with progression-free-survival about 26 months and overall survival of 63 months. [2, 4] The predilection of PMA is in the neuraxis, especially in the hypothalamus or optic chiasm. [2, 6, 10] Seldom, this tumor was found in the cerebellum and cervical spinal cord. [4, 6, 11, 12] Histologically, PMA shows marked myxoid matrix with small, compact, piloid, and highly monomorphic cells. Perivascular rosettes were often found. Different from PA, this tumor shows no Rosenthal fibers and rare eosinophilic granular bodies. [1, 12, 13] As with the majority of pediatric brain tumors, PMA most commonly presents with symptoms of increased ICP or parenchymal compression, including failure to thrive, developmental delay, altered level of consciousness, vomiting, feeding difficulties, and generalized weakness. [7, 9, 11, 14] Several studies revealed patients with decreased visual field and acuity while others reported the presence of diencephalic syndromes. [5, 6, 11] In cases of spinal cord PMA, the presenting symptoms are neck pain and weakness of extremities. [12, 14] Until this time, there were no definitive pathognomonic imaging findings to distinguish PMA from PA. [2, 8, 10] On head CT, PAs typically shows heterogeneous enhancement with a substantial cystic component, while PMAs typically enhance homogeneously and demonstrate solid composition; those facts could help in differentiating PMA from PA. [4] Hemorrhage due to spontaneous intratumoral bleeding was reported in PMA but not in PA; however it also requires further investigation. [10] In several studies, magnetic resonance imaging was used as a gold standard to differentiate PMA from PA but still did not reveal any specific difference. One study has suggested the usage of magnetic resonance spectroscopy to distinguish PMA from PA, although further studies were needed. [4, 10] The management for PMA is still controversial and was greatly influenced by tumor location. [1, 4] Gross total resection of newly diagnosed tumors, provided it can be performed without unacceptable sequelae, is the most powerful predictor of a favorable outcome in children. For the patient with hydrocephalus, CSF diversion by external drainage or VP-shunt could be performed. [9, 11] As for residual tumors, the role of adjuvant therapy is still questionable. [1] [2] [3] [4] Chemotherapy as an adjuvant therapy for PMA has been mentioned in several reports. For the time being, chemotherapy is usually applied judiciously for inoperable or partially resected tumors and may delay the need for radiotherapy in early childhood. Radiotherapy is generally reserved for patients older than
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Vol. 10, Issue 2, April-June 2015 5 years old after an initial surgical resection and have tumors located near the midline. [2, 10] In the authors' case, the treatment course was begun by performing CSF diversion by VP-shunt in order to manage the hydrocephalus followed by craniotomy tumor removal as the patient's general condition improved. Postoperative radiotherapy was performed, as the patient is considered old enough to accept the radiation dose. The patient's condition improved after the authors' course of treatment. Twenty-six months after radiotherapy, no clinical deterioration was reported, and the patient could perform her daily activities well. 
